CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues	$ 17,756,144	$ 16,475,558	$ 55,857,980	$ 51,716,260
Cost of revenues	13,840,744	11,232,819	41,636,950	35,015,540
Gross profit	3,915,400	5,242,739	14,221,030	16,700,720
Research and development	2,483,261	1,679,945	7,766,988	5,113,487
Selling, general, and administrative	8,812,458	9,306,622	31,828,451	23,442,282
Operating Expenses	11,295,719	10,986,567	39,595,439	28,555,769
Operating loss	(7,380,319)	(5,743,828)	(25,374,409)	(11,855,049)
Other income (expense):
Other income (expense), net	1,383,826	45,829	1,721,419	31,326
Interest expense	(1,305,820)	(10,663)	(3,168,118)	(25,380)
Nonoperating Income (Expense), Total	78,006	35,166	(1,446,699)	5,946
Loss from operations before provision for income taxes and noncontrolling interests	(7,302,313)	(5,708,662)	(26,821,108)	(11,849,103)
Provision for income taxes	26,151	285,976	907,628	1,191,179
Net loss	(7,328,464)	(5,994,638)	(27,728,736)	(13,040,282)
Less - net (loss) income attributable to noncontrolling interests	17,971	1,145,588	559,079	4,085,743
Net loss attributable to NeoStem, Inc.	(7,346,435)	(7,140,226)	(28,287,815)	(17,126,025)
Preferred dividends	150,655		508,070	153,469
Net loss attributable to NeoStem, Inc. common shareholders	$ (7,497,090)	$ (7,140,226)	$ (28,795,885)	$ (17,279,494)
Basic and diluted loss per share	$ (0.08)	$ (0.13)	$ (0.35)	$ (0.36)
Weighted average common shares outstanding	94,102,589	56,777,430	82,775,215	48,599,359